CO6270337A2 - Vacuna viva avirulenta de mycoplama hyopneumoniae con adyuvante - Google Patents

Vacuna viva avirulenta de mycoplama hyopneumoniae con adyuvante

Info

Publication number
CO6270337A2
CO6270337A2 CO10054267A CO10054267A CO6270337A2 CO 6270337 A2 CO6270337 A2 CO 6270337A2 CO 10054267 A CO10054267 A CO 10054267A CO 10054267 A CO10054267 A CO 10054267A CO 6270337 A2 CO6270337 A2 CO 6270337A2
Authority
CO
Colombia
Prior art keywords
hyopneumoniae
compositions
live
avirulent
adjuvant
Prior art date
Application number
CO10054267A
Other languages
English (en)
Inventor
Hsien-Jue Chu
Zhichang Xu
Wumin Li
Nicole Rae Gibson
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of CO6270337A2 publication Critical patent/CO6270337A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se proporcionan composiciones inmunogénicas y de vacuna y métodos para su preparacion y uso, siendo dichas composiciones eficaces para proteger contra, minimizar la gravedad de, prevenir y/o mejorar la infeccion por M. hyopneumoniae. La administracion a un animal de una o dos dosis de una composicion de M. hyopneumoniae vivo avirulento con adyuvante descrita en la presente memoria es eficaz para proporcionar inmunidad al animal y proteccion frente a la infeccion con una cepa virulenta de M. hyopneumoniae reduciendo de esta manera la gravedad y/o previniendo la enfermedad producida por una o mas cepas virulentas de M. hyopneumoniae, También se proporcionan composiciones que comprenden ademas uno o mas antigenos tales como, por ejemplo, una o mas bacterias vivas, bacterinas, toxoides y/o virus y/o antigenos virales. Se ejemplifican composiciones inmunogénicas que comprenden un M. hyopneumoniae vivo avirulento con adyuvante y composiciones que comprenden vacuna viva modificada de quimera de Tipo 1 - Tipo 2 de Circovirus Porcino (cPCV1-2) en combinacion adicional con M. hyopneumoniae vivo avirulento con adyuvante.
CO10054267A 2007-11-06 2010-05-06 Vacuna viva avirulenta de mycoplama hyopneumoniae con adyuvante CO6270337A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98581107P 2007-11-06 2007-11-06

Publications (1)

Publication Number Publication Date
CO6270337A2 true CO6270337A2 (es) 2011-04-20

Family

ID=40303616

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10054267A CO6270337A2 (es) 2007-11-06 2010-05-06 Vacuna viva avirulenta de mycoplama hyopneumoniae con adyuvante

Country Status (20)

Country Link
US (1) US9056909B2 (es)
EP (1) EP2217271B1 (es)
JP (1) JP5869221B2 (es)
KR (1) KR101225304B1 (es)
CN (2) CN101883581A (es)
AR (1) AR069216A1 (es)
AU (1) AU2008324780A1 (es)
BR (1) BRPI0820341B1 (es)
CA (1) CA2704775C (es)
CL (1) CL2008003304A1 (es)
CO (1) CO6270337A2 (es)
DK (1) DK2217271T3 (es)
HK (1) HK1198289A1 (es)
ME (1) ME01000B (es)
MX (1) MX2010005014A (es)
RU (1) RU2489164C9 (es)
TW (1) TWI513463B (es)
UA (1) UA98812C2 (es)
WO (1) WO2009061798A1 (es)
ZA (1) ZA201004026B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
PE20120909A1 (es) * 2009-05-19 2012-08-19 Bioproperties Pty Ltd Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usos de la misma
EA201291175A1 (ru) * 2010-05-19 2013-06-28 Байопропертис Пти Лтд. Способы, относящиеся к аттенуированной микоплазме
WO2013131565A1 (en) 2012-03-07 2013-09-12 Ceva Sante Animale Novel veterinary vaccine
CN105327344B (zh) * 2011-08-01 2019-03-05 普莱柯生物工程股份有限公司 含有猪圆环病毒2型抗原与副猪嗜血杆菌抗原的疫苗组合物及其制备方法与应用
CN103083658B (zh) * 2011-10-27 2015-09-02 普莱柯生物工程股份有限公司 一种用于治疗或预防猪感染性疾病的疫苗佐剂组合物
CN103157100B (zh) * 2011-12-08 2014-09-24 普莱柯生物工程股份有限公司 副猪嗜血杆菌病、猪链球菌病二联灭活疫苗及其制备方法
CN103157104B (zh) * 2011-12-14 2015-11-18 普莱柯生物工程股份有限公司 猪瘟疫苗的硫代硫酸钠稀释液
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) * 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
CN104685057B (zh) * 2012-07-10 2019-04-16 海博莱科学有限公司 用于转化猪肺炎支原体的载体，转化的猪肺炎支原体菌株及其用途
EP2684959A1 (en) * 2012-07-10 2014-01-15 Laboratorios Hipra, S.A. Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
CN103623400B (zh) * 2012-08-24 2016-08-17 普莱柯生物工程股份有限公司 抗猪支原体肺炎、传染性胸膜肺炎疫苗组合物及制备方法
CN103861095B (zh) * 2012-12-11 2016-03-09 普莱柯生物工程股份有限公司 含猪支原体肺炎抗原和猪链球菌病抗原的疫苗组合物及其制备方法和应用
MX361273B (es) * 2012-12-28 2018-12-03 Boehringer Ingelheim Vetmedica Gmbh Metodo para obtener una vacuna de mycoplasma.
EA038206B1 (ru) 2012-12-28 2021-07-23 Бёрингер Ингельхайм Ветмедика Гмбх Иммуногенная композиция, содержащая антигены микоплазм
WO2014182872A1 (en) 2013-05-08 2014-11-13 Protatek International, Inc. Vaccine for pcv2 and mycoplasma
CN104338128B (zh) * 2013-07-31 2017-09-05 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
CN109078179A (zh) * 2013-09-05 2018-12-25 硕腾服务有限责任公司 Hendra和Nipah病毒G糖蛋白免疫原性组合物
CN104248759B (zh) * 2013-11-19 2017-05-10 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
US10279031B2 (en) * 2016-05-11 2019-05-07 Phibro Animal Health Corporation Composition comprising antigens and a mucosal adjuvant and a method for using
US10519199B2 (en) * 2016-08-12 2019-12-31 Innovac Vaccine composition comprising recombinant protein for preventing swine Mycoplasma infection
CN109234418B (zh) * 2018-11-20 2021-08-13 湖南中净生物科技有限公司 一种鉴别猪肺炎支原体野毒株和疫苗株的引物、试剂盒和方法
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN112143666B (zh) * 2020-09-07 2023-02-21 华中农业大学 一种猪肺炎支原体弱毒株及其在制备弱毒疫苗中的应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917619A (en) 1972-03-06 1975-11-04 Bayer Ag 2-Amino-4,5-dihydropyridine derivatives
JPS5540568B2 (es) * 1972-10-05 1980-10-18
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
FR2565825B1 (fr) 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
JPS62273456A (ja) 1986-05-21 1987-11-27 Tosoh Corp 分析装置用に用いるテストカツプのシ−ル箔破開用シ−ルブレ−カ
JPH0795069B2 (ja) * 1986-05-22 1995-10-11 農林水産省家畜衛生試験場長 マウスＩｇＡ単クローン抗体を用いる豚マイコプラズマ肺炎の診断方法
EP0283840A3 (en) 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneumoniae antigen and uses therefor
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP0571648A1 (en) 1992-05-26 1993-12-01 Chung-Nan Weng Vaccine protecting against mycoplasmal pneumonia
BE1008978A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
ZA9710606B (en) * 1996-12-05 1998-06-12 Akzo Nobel Nv Non-virulent Mycoplasma synoviae vaccine thereof.
JP2003513935A (ja) * 1999-11-08 2003-04-15 バイオミューン マイコプラズマ・ボビスに対するワクチンおよび使用方法
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
US7018638B2 (en) 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
JP2004537543A (ja) * 2001-07-02 2004-12-16 ファイザー・プロダクツ・インク マイコプラズマ・ハイオニューモニエ・ワクチンおよび牛におけるマイコプラズマ・ボビス低減方法
BR0210804A (pt) 2001-07-02 2005-05-03 Pfizer Prod Inc Vacinação de dose única com mycoplásma hyopneumoniae
MXPA04000680A (es) 2001-07-27 2004-04-05 Wyeth Corp Vacuna para virus west nile.
US20030129161A1 (en) 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
CA2481042A1 (en) * 2002-04-05 2003-10-23 Walter H. Hsu Mycoplasma polypeptides
TWI350174B (en) 2003-03-12 2011-10-11 Wyeth Corp Adjuvanted bovine vaccines
RU2278704C2 (ru) * 2004-01-12 2006-06-27 Алексей Борисович Башкиров Метод индукции иммунного ответа организма млекопитающих-2

Also Published As

Publication number Publication date
CL2008003304A1 (es) 2009-01-09
RU2010117614A (ru) 2011-12-20
UA98812C2 (ru) 2012-06-25
TWI513463B (zh) 2015-12-21
CA2704775C (en) 2016-05-10
KR20100087202A (ko) 2010-08-03
BRPI0820341B1 (pt) 2021-11-09
EP2217271A1 (en) 2010-08-18
EP2217271B1 (en) 2016-05-04
WO2009061798A1 (en) 2009-05-14
HK1198289A1 (en) 2015-03-27
CN101883581A (zh) 2010-11-10
DK2217271T3 (en) 2016-06-06
ZA201004026B (en) 2011-04-28
KR101225304B1 (ko) 2013-01-22
MX2010005014A (es) 2010-06-30
JP5869221B2 (ja) 2016-02-24
CA2704775A1 (en) 2009-05-14
AU2008324780A1 (en) 2009-05-14
US9056909B2 (en) 2015-06-16
JP2011503086A (ja) 2011-01-27
RU2489164C9 (ru) 2014-01-20
CN104043116A (zh) 2014-09-17
RU2489164C2 (ru) 2013-08-10
US20090117152A1 (en) 2009-05-07
BRPI0820341A2 (pt) 2020-05-19
TW200927166A (en) 2009-07-01
ME01000B (me) 2012-10-20
AR069216A1 (es) 2010-01-06

Similar Documents

Publication Publication Date Title
CO6270337A2 (es) Vacuna viva avirulenta de mycoplama hyopneumoniae con adyuvante
AR069882A1 (es) Circovirus porcino, molecula de acido nucleico aislada que lo codifica, composicion inmunogenica que lo comprende, vector que comprende por lo menos una molecula de acido nucleico exogena que codifica una proteina de circovirus porcino y metodos para inmunizar un cerdo contra la infeccion virica o e
NI202000040A (es) Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y métodos de uso de estos
BR112012023046A2 (pt) vacinas de vírus de febre aftosa recombinantes e seus respectivos usos
PE20211545A1 (es) Dosis unitaria de vacuna contra el dengue y administracion de esta
MX2009006178A (es) Vacuna contra salmonela.
CO6361948A2 (es) Uso de antigeno de mycoplasma bovis
AR052625A1 (es) Nueva composicion
AR064009A1 (es) Metodo de inmunizacion contra los 4 serotipos del dengue
CO6460761A2 (es) Vacuna viva modificada de mycoplasma bovis mejorada, métodos de producción de vacunas vivas de mycoplasma bovis, vacunas de combinación y métodos de tratamiento
BR112015005056A2 (pt) vacinas de combinação com sorogrupo b meningococcus e d/t/p
CO6280408A2 (es) Vacuna de virus de la lengua azul y composiciones inmunogenicas procedimientos de uso y procedimeintos de la produccuion de la misma
CR8638A (es) Vacuna agalactiae estreptococos
PE20151588A1 (es) Vacuna contra el virus del dengue
BR112021024491A8 (pt) Composição imunogênica, e, método para prevenir, tratar ou melhorar uma infecção, doença ou condição
CO2019000214A2 (es) Vacuna contra virus de bronquitis infecciosa
UY31437A1 (es) Vacuna de mycoplasma bovis y métodos de uso de la misma
AR103427A1 (es) Vacuna contra la fiebre aftosa
PE20140871A1 (es) COMPOSICIONES Y METODOS DE VACUNA DEL VIRUS TIPO 1b DE DIARREA VIRAL BOVINA
BR112012021650A2 (pt) "parvovírus recombinante atenuado, vacina para a proteção de animais contra infecção com parvovírus, método para a obtenção de um parvovírus recombinante, e, uso de uma vacina."
CL2007002710A1 (es) Formulacion inmunogenica que confiere proteccion contra la infeccion o patologia causada por el virus respiratorio sincicial (vrs) que comprende una cepa recombinante atenuada de mycobacterium; y uso de la formulacion inmunogenica para preparar una vacuna para prevenir, tratar o atenuar infecciones del vrs.
CO2023003242A2 (es) Vacuna contra el coronavirus y procedimiento para la preparación de la misma
CO2022012272A2 (es) Vacunas contra el coronavirus y métodos de uso
NZ743977A (en) M hyo multivalent vaccine and uses thereof
BR112018069100A2 (pt) uma vacina combinada contra a infecção por vírus pcv2 e mycoplasma hyopneumoniae

Legal Events

Date Code Title Description
FC Application refused